TECENTRIQ ATEZOLIZUMAB INJECTION FOR INTRAVENOUS USE 1200 MG
Live / Registered — Registered (as of 05 Oct 2021)
What this means for you
Registered since 05 Oct 2021. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90318619
- Registration number
- 6506351
- Mark type
- Design + words
- Filed
- 13 Nov 2020
- Published for opposition
- 20 Jul 2021
- Registered
- 05 Oct 2021
- Attorney of record
- Jelena Libby
Goods and services
- Class 044 — Medical, beauty and agricultural services: Providing online information services, namely, prescription drug information in relation to the treatment and symptoms of disorders relating to oncology, autoimmune, or inflammatory diseases
Owner
- Genentech, Inc., South San Francisco, CA, US
- Genentech, Inc., South San Francisco, CA, US
- Genentech, Inc., South San Francisco, CA, US
Prosecution history
- 19 Apr 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 19 Apr 2023 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 19 Apr 2023 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 19 Apr 2023 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 25 Aug 2022 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 25 Aug 2022 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 25 Aug 2022 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 25 Aug 2022 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 05 Oct 2021 — REGISTERED-PRINCIPAL REGISTER
- 20 Jul 2021 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 20 Jul 2021 — PUBLISHED FOR OPPOSITION
- 30 Jun 2021 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 17 Jun 2021 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 17 Jun 2021 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 17 Jun 2021 — CORRESPONDENCE RECEIVED IN LAW OFFICE